Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma

Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is a rare type of B-cell Non-Hodgkin lymphoma (NHL) affecting predominantly male patients. While complete remissions following first-line treatment are frequent, most patients ultimately relapse, with a usually aggressive further disease course. The use of cytarabine-compr...

Full description

Bibliographic Details
Main Authors: Alexander D. Heini, Ulrike Bacher, Naomi Porret, Gertrud Wiedemann, Myriam Legros, Denise Stalder Zeerleder, Katja Seipel, Urban Novak, Michael Daskalakis, Thomas Pabst
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cells
Subjects:
mantle cell lymphoma (MCL)
CAR T
expansion
relapse
glofitamab
Online Access:https://www.mdpi.com/2073-4409/11/17/2747

Internet

https://www.mdpi.com/2073-4409/11/17/2747

Similar Items